While thrombotic microangiopathy is acknowledged as a classification criterion for definite APS (small vessel thrombosis), the association between various aPL was inconsistent across studies, and it was unclear whether the frequency of chronic lesions was significantly higher in aPL-positive SLE patients compared with aPL-negative SLE patients. This evidence concerns the gene FASLG and Genetic thrombotic microangiopathy.